Baseline Characteristics of Patients with Relapsing-Remitting Multiple Sclerosis Transitioning to Alemtuzumab in the Real-World PRO-ACT Study
MULTIPLE SCLEROSIS JOURNAL(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
MULTIPLE SCLEROSIS JOURNAL(2019)